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Objectives: to compare the efficacy and cost-effectiveness of ultrasound-guided compression (UGC) with ultrasound-
guided thrombin injection (UGTI) for treatment of postcatheterisation arterial false aneurysms (cFA).
Design: prospective clinical study using historical controls.
Materials and Methods: we prospectively collected data on 33 consecutive patients diagnosed with cFA larger than
1.5 cm in diameter. These were treated with UGTI. We performed a retrospective review of data on a former group of 33
consecutive historical control patients that were treated by UGC.
Results: the groups were similar in respect of demographic and clinical variables. Thirty patients were suitable for UGC
and 33 patients were suitable for UGTI. The success rate for UGC was 26/30 (87%) compared to 33/33 (100%) for UGTI
(p<0.05). Thrombosis was achieved during the first treatment session in 7/26 patients treated by UGC, compared to 26/
33 in the UGTI group (p<0.0001). Four patients that failed UGC and two patients that were unsuitable for UGC
required surgical repair. UGTI as compared to UGC was shorter in duration (25 vs 75 min) and required no sedation.
No thromboembolic or systemic complications occurred in either group. Cost analysis revealed savings of $US 517 for
each patient treated by UGTI as compared with UGC.
Conclusions: in our study, UGTI is superior to UGC, and we suggest that UGTI should become the procedure of choice
for the treatment of cFA.
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Introduction patients with cFA treated with ultrasound-guided per-
cutaneous injection of thrombin.4 This report was
Postcatheterisation false aneurysms (cFA) occur in less quickly followed by several similar publications.5–10
Subsequently, various concerns have been raised re-than 1% of cases.1 Poor puncture-site selection, use of
large-bore needles and sleeves, interventional pro- garding possible complications of this treatment, e.g.
thromboembolic or allergic reactions.11,12 We reviewedcedures, periprocedural use of anticoagulant and anti-
thrombotic agents, poor control of the puncture-site our experience with both treatment modalities and
evaluated the efficacy and cost efficiency of UGC vsbleeding upon retrieval of the catheter as well as
calcified arteries are all associated with an increased UGTI.
rate of this complication. cFA was treated surgically
until 1991 when ultrasound-guided compression-clos-
ure (UGC) was introduced.2 UGC rapidly replaced
surgery as the treatment modality of first choice, al-
though the success rate was only about 75% and
Materials and Methodsit had several limitations, including significant local
discomfort and a significant rate of recurrence. In 1986 All patients with suspected cFA were evaluated byCope et al. reported percutaneous injection of thrombin diagnostic duplex scan in our noninvasive vascularto treat false aneurysms, with occlusion of the feeding laboratory with an ultrasound scanner (Synergy, Gen-vessel.3 In 1997 Liau et al. published a series of 5 eral Electric, U.S.A.), utilising a 5-MHz linear array
transducer. We recorded the luminal diameter of the
∗ Please address all correspondence to: E. E. Weinmann, Department cFA and the status of the peripheral pulses and arterialof Vascular Surgery, Assaf Harofeh Medical Center, Zerifin 70300,
Israel. blood flow of all extremities. All patients with cFA
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with a luminal diameter larger than 1.5 cm were con- next morning to confirm complete obliteration. In a
few cases of obese patients or huge haematomas wesidered for non-invasive treatment. Patients with smal-
experienced exceptionally poor visualisation of theler cFA were followed by repeat duplex scans till
needle tip by duplex. Subsequently we used speciallyspontaneous obliteration of the aneurysm and were
designed needles with echogenic tips (Echotip, 21-excluded from this study.
gauge 10-centimetre long needle, Cook, Bloomington,Between July 1999 and February 2001 we pro-
IN, U.S.A.) that enabled more reliable confirmationspectively collected data on 33 consecutive patients
of proper positioning of the needle tip inside thediagnosed with cFA that were treated by UGTI. This
aneurysmal sac.group included 6 patients from other hospitals referred
for UGTI in our institution. We compared this group
to a historic control group of 33 consecutive patients
with cFA that were treated with UGC between June Results
1997 and June 1999. We reviewed the charts, non-
invasive vascular laboratory findings and outpatient Comparison of the treatment groups
follow-up records of all patients.
UGC was performed in a routine fashion under The UGC and UGTI groups were similar with regard
continuous ultrasonographic guidance as previously to age (66 vs 65 years) and male to female distribution
described by Fellmeth et al.2 Briefly, compression of (15:18 vs 14:19, respectively). There were no significant
the aneurysmal neck to arrest flow in the cFA sac was differences between the treatment groups regarding
applied for 15 min, up to 3 times in sequence, during underlying medical conditions, e.g. ischaemic or
one treatment session. If obliteration of the cFA was rheumatic heart disease, hypertension, cigarette smok-
not achieved the same procedure was repeated the ing and hyperlipidaemia. The groups were comparable
following day, up to a maximum of three sessions. regarding the ratio of interventional vs diagnostic
Analgesics and sedative premedication were routinely procedures, and cardiac vs peripheral catheterisations.
required to ease the discomfort during the procedure All cFA were of the femoral artery, except 2 cases of
and enable effective compression. Anticoagulant and brachial artery cFA in the UGTI group. The median
anti-platelet treatments were regularly discontinued diameter of the cFA was 2.37 cm (range: 1.50–5.25 cm)
to facilitate successful thrombosis of the aneurysms. in the UGC group and 2.25 cm (range: 1.50–4.53 cm)
Patients rendered unsuitable for UGC and patients in the UGTI group.
that failed UGC were operated.
UGTI was performed according to the method pre-
viously described by Kang et al.5 Bovine thrombin
Ultrasound-guided compressionsolution (GENTRAC Inc., Middleton, WI, U.S.A.), at
a concentration of 1000 u/m after reconstitution of
Treatment by UGC was considered in 33 consecutivethrombin powder in sterile normal saline, was drawn
patients (Table 1). One patient died prior to treatmentinto a 2-millilitre syringe attached to a 21 or 22-gauge
and in 2 patients UGC could not be performed due tospinal needle. The skin was prepped with chlor-
underlying medical conditions, e.g. severe obesity andhexidine gluconate 0.5% in alcohol 70% solution and
unstable cardiac condition. In 26/30 (87%) UGC wasthe needle was inserted into the cFA under continuous
successful, though in 19/30 (63%) more than onesonographic guidance with the color-flow turned off.
session of compression was required. No systemicWith the tip of the needle inside the aneurysmal lumen
complications have been reported, though the vastand the color-flow turned on, thrombin solution was
majority of the patients had large groin hematomasgently injected, resulting in a visible acoustic noise on
that resolved spontaneously. One out of 6 patients thatthe screen. Obliteration of the cFA was detected by
required surgery had a prolonged hospitalisation duecomplete disappearance of the color-flow signal inside
to a severe operative wound infection. No late failuresthe cFA, usually within a few seconds, and the needle were revealed.
was removed. If obliteration of the cFA lumen failed,
1–2 similar doses of thrombin were repeatedly injected.
We did not apply any local compression and re-
markably none of the patients required any analgesic Ultrasound-guided thrombin injection
or sedative treatment. Anticoagulant and anti-platelet
medication was not modified in this group. All patients Thirty-three consecutive patients with cFA were
offered UGTI as the first treatment modality (Tablewere kept in bed for 4 h and were re-examined the
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Table 1. Results. Comparison of the procedure-related outcome of patients allocated for treatment
by UGC and UGTI.
UGC UGTI
Pre-treatment mortality 1 (3%) 0
Patients unsuitable for treatment modality 2 0
Catheterisation-treatment interval (days) 2 (1–30) 3 (1–30)
Thrombin (units/injection) n/a 300 (100–3000)
Patients available for non-surgical treatment 30 33
successful obliteration 26 (87%) 33 (100%)
on-table obliteration, 1st session 7 (23%) 26 (79%)
on-table obliteration, 2nd session 11 (37%) 6 (18%)
delayed spontaneous obliteration 8 (27%) 1 (3%)
failure of treatment 4 (13%) 0 (0%)
noninvasive vascular lab stay (min/pt) 75 (15–120) 25 (15–60)
procedure-related hospital stay (days/pt) 2 (1–5) 1 (1–2)
complications: superficial skin infection 2 (7%) 1 (3%)
patients treated surgically 6 (20%) 0 (0%)
operating room time (h/case) 1.5 (1–2) n/a
post-operative hospital stay (days/pt) 3 (2–24) n/a
complications: surgical wound infection 1 n/a
Values represent number of patients, except when otherwise noted. Average values are presented as
median and range, in parentheses. (UGC – ultrasound-guided compression therapy, UGTI – ultra-
sound-guided thrombin injection, pt – patient, n/a – not appicable).
1). UGTI was applicable and resulted in complete Cost analysis
obliteration of the cFA in all patients (100%). In 26/33
(79%) the cFA thrombosed completely during the ini- We performed a limited cost analysis based on local
charges (expressed in US$) for non-invasive vasculartial treatment session and only 6/33 (18%) required a
second session of UGTI. In addition, one patient with laboratory, operating room, hospitalisation and throm-
bin, but excluding other charges, e.g. surgeons’ fee.a brachial cFA that completely obliterated initially was
found with a patent cFA on next day evaluation and Time utilisation of the noninvasive vascular laboratory
was more than twice in the UGC group compared torequired repeated UGTI. One patient with superficial
skin infection in the groin required treatment with the UGTI group. Failure to obliterate most of the cFA
by UGC on the first session required an additionaloral antibiotics. No adverse reactions of immunologic
origin or any other systemic complications have oc- day of hospitalisation for those patients. Six patients
in the UGC group required surgery (average 1.5 hcurred. Two patients reported transient pain of a few
seconds’ duration distal to the injection site im- operating room per case) that was followed by an
average post-operative hospital stay of 6.7 days permediately following thrombin injection. Careful ex-
amination of the peripheral pulses and doppler studies patient, a relatively prolonged period that resulted
from a significant operative wound infection in oneof the extremities did not detect any objective signs of
embolisation. Unlike in the UGC group, this procedure of the patients. The success in obliterating most cFA
by UGTI on the first session and the fact that nonewas associated with minimal discomfort of the 21-
gauge needle stick and resulted in a uniform pattern of the patients in the UGTI group required surgery
translated to significant cost savings in this group,of patient satisfaction. No late failures were revealed.
about US$517/patient, or 45% relative cost reduction
(Table 2).
Statistical analysis
We compared the proportion of successful treatment
among the two study groups, using Fisher’s exact test. Discussion
This test is appropriate due to the relatively small size
of the study and the small expected frequency. The UGC has been judged to be effective with a success
rate of up to 88% in a recent study.14 Nevertheless,overall success rate of UGTI reached statistical dif-
ference compared to UGC (p=0.0460). The difference surgical intervention is still required in failed cases.
UGC is often associated with considerable discomfortin favor of UGTI in achieving fast cure during the first
treatment session was highly significant (p<0.0001). to the patient, it requires repeat duplex studies and
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Table 2. Expenses. The expenses are calculated as average for one treated patient, based
on local costs expressed in US$.
UGC UGTI
Noninvasive vascular lab utilisation ($90/h)
diagnostic study (15 min/study) 22 22
treatment session (75 min/UGC, 25 min/UGTI) 114 39
completion study (15 min/study) 22 22
follow-up study (15 min/study) 22 22
Thrombin solution ($96/vial) 0 96
Post-procedure hospitalisation ($360/day) 792 432
Operating room utilisation (1.5 h/case) 98 0
Post-operative hospitalisation ($360/day) 80 0
Total 1150 633
(UGC – ultrasound-guided compression therapy, UGTI – ultrasound-guided thrombin
injection, $ – US$).
relatively prolonged noninvasive vascular laboratory embolisation could be detected by physical ex-
amination or doppler studies, we speculated that thoseutilisation.
The initially published series on UGTI revealed its symptoms could have been caused by possible micro-
emboli that rapidly lysed due to normal thrombolyticexcellent success rate but failed to deal convincingly
with the concerns of thromboembolic or other systemic reactions in the circulation.
We were also puzzled by the case of a patient withcomplications, e.g. allergic reactions. A report on a
thromboembolic complication of UGTI for a brachial a brachial cFA that ‘‘recanalised’’ on repeat duplex
24 h following successful UGTI, without evidence ofartery cFA11 and a report on a case of extensive femoral
artery thrombosis following UGTI of a femoral cFA re-bleeding or embolisation. A second attempt of UGTI
resulted in complete obliteration of the cFA. We spec-(unpublished communication) further emphasised the
significance of those concerns. ulated that a factor such as the size of the needle-hole,
the configuration of the aneurysm and its neck, orWe compared the results of UGTI in a prospective
consecutive series of patients to the results of UGC in an undetected coagulation abnormality could have
contributed to this outcome. Because lack of any ob-a historic control group of consecutive patients treated
previously in our hospital. Unlike in prospective ran- jective evidence of detectable arterial embolisation, we
did not alter our approach and continue to offer UGTIdomised trials a selection bias can not be completely
excluded in this study, yet the results are in agreement as the first treatment modality for patients with cFA.
Nevertheless, we initiated a study to elucidate thewith those previously published in the literature. We
feel that the importance of those results in a new haemodynamic and pharmacologic mechanisms in-
volved in this novel procedure.treatment modality outweight the shortcomings of the
study design. There was a significant variability in the amount of
thrombin required to achieve obliteration of the cFA,At the initiation of UGTI in our institution we
carefully monitored each procedure with particular partially due to inter-operator variation. According to
the experience of the senior author (EEW) 100–200attention to possible thromboembolic complications.
Precise visualisation of the tip of the injecting needle units of thrombin are usually sufficient to induce
thrombosis, though occasionally a second injection isinside the lumen of the cFA was an absolute condition
before injection of thrombin. Thrombin was very required, particularly when there is more than one
‘‘loculation’’ of the cFA.gently injected to avoid from a possible jet of the
solution to reach the lumen of the native artery. Taylor et al.7 compared UGTI to UGC and dem-
onstrated significant reduction in cost for this pro-All patients were screened for history of allergy, or
exposure to thrombin during former cardiovascular cedure, yet the hospital charges were not influenced
significantly because their patients required continuedsurgery. We also prepared ourselves to treat possible
systemic reactions, as recently suggested.12 Two of our hospitalisation due to their severe illnesses. In our
study significant cost savings resulted from the factpatients reported on sudden pain of a few seconds’
duration in their legs, just distal to the injection site. that none of the patients in the UGTI group required
surgery and post-operative hospitalisation. GainingAlthough no objective evidence for possible arterial
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